ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Accolade Inc

Accolade Inc (ACCD)

3.46
0.04
(1.17%)
Closed July 13 4:00PM
3.47
0.01
(0.29%)
After Hours: 6:16PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
3.47
Bid
3.43
Ask
3.48
Volume
1,323,709
3.41 Day's Range 3.585
3.35 52 Week Range 15.36
Market Cap
Previous Close
3.42
Open
3.45
Last Trade
50
@
3.48
Last Trade Time
Financial Volume
$ 4,590,451
VWAP
3.4679
Average Volume (3m)
1,024,358
Shares Outstanding
80,008,376
Dividend Yield
-
PE Ratio
-2.77
Earnings Per Share (EPS)
-1.25
Revenue
414.29M
Net Profit
-99.81M

About Accolade Inc

Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members. Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members.

Sector
Business Services, Nec
Industry
Business Services, Nec
Headquarters
Wilmington, Delaware, USA
Founded
1970
Accolade Inc is listed in the Business Services sector of the NASDAQ with ticker ACCD. The last closing price for Accolade was $3.42. Over the last year, Accolade shares have traded in a share price range of $ 3.35 to $ 15.36.

Accolade currently has 80,008,376 shares outstanding. The market capitalization of Accolade is $273.63 million. Accolade has a price to earnings ratio (PE ratio) of -2.77.

ACCD Latest News

Nike Stock Drops 14% in Pre-Market; Nokia Acquires Infinera for $2.3 Billion, and More News

Nike (NYSE:NKE) – Nike shares fell 14.04% in pre-market trading. Nike exceeded fourth-quarter fiscal earnings estimates with adjusted earnings of $1.01 per share, but sales of $12.6 billion...

Accolade Announces Results for Fiscal First Quarter 2025

SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. “Accolade's physician-led advocacy...

U.S. Futures Decline Ahead of Key Economic Events, Oil Prices Rise

U.S. index futures point to a lower opening on Thursday, influenced by a disappointing revenue forecast from chipmaker Micron Technology (NASDAQ:MU), with focus on the release of Q1 GDP this...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1-2.801120448183.573.673.3520214923.46417614CS
4-2.92-45.6964006266.396.413.3518243554.39930952CS
12-5.61-61.78414096929.089.673.3510243585.83919CS
26-10.98-75.986159169614.4514.733.358135267.95770796CS
52-10.3-74.800290486613.7715.363.357065809.20300805CS
156-50.3-93.546587316353.7754.5153.3581458813.53510093CS
260-31.53-90.08571428573565.253.3576622320.08064453CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.65M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

ACCD Discussion

View Posts
Monksdream Monksdream 2 weeks ago
ACCD new 52 week low
👍️0
Monksdream Monksdream 11 months ago
That awful Cathie Wood bought more shares

👍️0
Monksdream Monksdream 12 months ago
ACCD That awful Cathie Wood bought shares.
Accolade Inc NASDAQ: ACCD

GoSymbol lookup
Health Care : Health Care Providers & Services | Small Cap BlendCompany profile
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
👍️0
forthepeach forthepeach 2 years ago
Will this help their stock price?
https://finance.yahoo.com/news/accolade-expands-mental-health-integrated-130000009.html
👍️0
swampboots swampboots 2 years ago
ACCD down 50% will lose big customer end of year and always has loses on increased revenue, spends a ton on research and dev.
👍️0
crudeoil24 crudeoil24 3 years ago
Accolade Sees Q4 Sales $90M-$93M vs $97.71M Est., Raises FY22 Sales Guidance From $303M-$307M To $306M-$309M vs $306.34M Est.
👍️0
crudeoil24 crudeoil24 3 years ago
Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The Company leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.
👍️0

Your Recent History

Delayed Upgrade Clock